Sequential Multiple Assignment Randomized Trial for Bipolar Depression
This research study is for adults (aged 18-75) with bipolar disorder who are currently experiencing a depressive episode. It's looking at four different treatment options: Cariprazine, a combination of Aripiprazole and Escitalopram, Quetiapine, and Lurasidone. The main goal is to find out which of these commonly used treatments works best to help people feel better. Researchers also want to understand what to do if the first treatment doesn't fully work, and how to help people stay well over time. Participants will be followed for up to 52 weeks to see how they respond to the treatments.
At a glance
What is this study about?
This study is a bit like a big experiment comparing different ways to treat bipolar depression in adults. Researchers want to understand the best approaches to help people with bipolar disorder who are feeling very low. They're looking at four different medications or combinations of medicines that doctors often prescribe for bipolar depression.
The study has a clever design: if the first treatment you try doesn't fully help, you might get the chance to try a different treatment that wasn't used initially. This helps researchers learn what works when a person needs a second option. All participants will be checked on regularly for about a year to see how they're doing with their treatment, how they're feeling, and if the treatment helps them stay well.
Before the main study starts, a smaller "feasibility" phase is happening. This is to make sure everything runs smoothly at a few locations before expanding to all chosen sites. They'll test if it's easy to find people who want to join, if they stay in the study, and if all the procedures work correctly. This step helps ensure the larger study will be well-organised and successful.
Key takeaways
- This study compares four common treatments for bipolar depression.
- It aims to find the best first-line and second-line treatments.
- Adults aged 18-75 with current bipolar depression can take part.
- Participants will be followed for up to 52 weeks.
- It's exploring how to help people get well and stay well.
- You might try a different treatment if the first one isn't fully effective.
Who may be eligible?
This study is looking for adults aged between 18 and 75 years old. To join, you must have been diagnosed with Bipolar I or Bipolar II disorder and currently be experiencing a depressive episode that has lasted for at least two weeks. You should also be able to be looked after as an outpatient, meaning you don't need to stay in a hospital for your care, and be willing to try one of the study treatments at random.
There are also some reasons why you might not be able to join. For example, if you are currently having a manic episode, or if your mood changes very quickly (four or more times a year). People with a history of schizophrenia or other types of psychosis, or those with current serious substance use issues that would affect their ability to take part, cannot join. If you're pregnant or breastfeeding, you also wouldn't be able to participate. Also, if you've had a bad reaction to any of the study medications before, or if a doctor determined that taking the study medications would not be clinically good for you, you won't be able to participate.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 75 years old?
- Do you have a diagnosis of Bipolar I or Bipolar II disorder?
- Are you currently experiencing a depressive episode that has lasted at least 2 weeks?
- Can you be looked after as an outpatient (not requiring hospital stay)?
- Are you willing to try a randomly assigned study treatment?
- Are you NOT pregnant or breastfeeding?
What does participation involve?
If you decide to take part, you'll be randomly assigned to one of the four study treatments. This is similar to drawing names out of a hat. You'll have regular check-ups and assessments to monitor how you're feeling and how the treatment is working. These appointments will involve answering questions and potentially some other simple tests.
If the first treatment you receive doesn't fully help with your depression after about 6 weeks, you might be given the option to try a different study treatment, again chosen at random from the remaining options. All participants will be followed for a full year (52 weeks) from the start of the study. This helps the researchers understand the long-term effects of the treatments and how they help people stay well.
Potential risks and benefits
Locations (18)
- University of Alabama BirminghamVerified postcodeBirmingham, United States
- Steve StrakowskiVerified postcodeBloomington, United States
- John HopkinsVerified postcodeBaltimore, United States
- McLean HospitalVerified postcodeBelmont, United States
- Massachusetts General HospitalVerified postcodeBoston, United States
- University of MichiganVerified postcodeAnn Arbor, United States
- Nagy YoussefVerified postcodeGrand Rapids, United States
- University of New Mexico Health Sciences Center AlbuquerqueVerified postcodeAlbuquerque, United States
- New York University Grossman School of Medicine NYUVerified postcodeNew York, United States
- Montefiore Medical Center and Albert Einstein College of MedicineVerified postcodeNew York, United States
- University of North Carolina at Chapel HillVerified postcodeChapel Hill, United States
- Case Western Reserve UniversityVerified postcodeCleveland, United States
Common questions
What is Bipolar I or Bipolar II disorder?
These are types of bipolar disorder, a condition where people experience significant mood changes, including periods of high energy (mania or hypomania) and periods of low mood (depression).
What is a 'depressive episode'?
This refers to a period where someone feels very low, sad, or loses interest in activities they usually enjoy, among other symptoms like changes in sleep or appetite.
What does 'randomized' mean?
It means you're assigned to a treatment group by chance, like flipping a coin. This ensures the study is fair and the results are reliable.
What does a 'sequential multiple assignment' study mean?
It means that if your first treatment doesn't work, you might be offered another treatment option from the study, rather than just stopping.
Will I know which treatment I'm receiving?
The study information doesn't specify if it's 'blinded,' meaning you might or might not know which specific medication you're on. Your study doctor can clarify this.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.